Schroder Investment Management Group

Schroder Investment Management Group’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Schroder Investment Management Group’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-310,499	Closed	-$590K	–	1219
2023 Q4	$590K	Buy	+310,499	New	+$464K	﹤0.01%	1067
2022 Q3	–	Sell	-248,287	Closed	-$2.7M	–	1309
2022 Q2	$2.7M	Buy	248,287 +187,046	+305%	+$2.24M	﹤0.01%	920
2022 Q1	$1.16M	Buy	61,241 +16,617	+37%	+$426K	﹤0.01%	1108
2021 Q4	$919K	Buy	44,624 +22,691	+103%	+$1.36M	﹤0.01%	1046
2021 Q3	$691K	Sell	21,933 -2,581	-11%	-$187K	﹤0.01%	1164
2021 Q2	$2.06M	Buy	+24,514	New	+$1.62M	﹤0.01%	1011

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Caligan Partners New York $1.41B AUM 518.95% 1-Year Est. Return

Two Sigma Advisers

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Temasek Holdings

Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

Exome Asset Management New York $170M AUM 208.51% 1-Year Est. Return

EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return